Medimmune - Company & Market Research Reports

MedImmune is a biologics research and development company that develops medicines for unmet medical needs across therapeutic areas, including respiratory, inflammation, and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and vaccines worldwide. The company has one of the largest, most robust pipelines in the industry — including more than 120 research projects and product candidates. The company was incorporated in 1987 and is based in Gaithersburg, Maryland.

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market - Product Thumbnail Image

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

  • Report
  • 197 Pages
From
Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018

  • Report
  • 82 Pages
From
Pneumonia Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Pneumonia Drug Development Pipeline Review, 2017

  • Report
  • 123 Pages
From
Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers - Product Thumbnail Image

Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers

  • Report
  • 155 Pages
From
Global Human Papillomavirus Infection Drug Market & Clinical Trials Insight 2023 - Product Thumbnail Image

Global Human Papillomavirus Infection Drug Market & Clinical Trials Insight 2023

  • Report
  • 220 Pages
From
Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment - Product Thumbnail Image

The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment

  • Report
  • 320 Pages
From
Global Regenerative Medicine Market Analysis & Forecast to 2021 - Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries - Product Thumbnail Image

Global Regenerative Medicine Market Analysis & Forecast to 2021 - Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

  • Drug Pipelines
  • 682 Pages
From
Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 265 Pages
From
Global Regenerative Medicine Market Analysis & Forecast to 2022; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries - Product Thumbnail Image

Global Regenerative Medicine Market Analysis & Forecast to 2022; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

  • Report
  • 682 Pages
From
Peptide Therapeutics in Metabolic Disorders, 2016 - 2025 - Product Thumbnail Image

Peptide Therapeutics in Metabolic Disorders, 2016 - 2025

  • Report
  • 436 Pages
From
Ventilator Associated Pneumonia R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Ventilator Associated Pneumonia R&D Pipeline Analysis Report, H2-2018

  • Report
  • 110 Pages
From
Hospital Acquired Pneumonia (HAP) R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Hospital Acquired Pneumonia (HAP) R&D Pipeline Analysis Report, H2-2018

  • Report
  • 120 Pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

  • Report
  • 350 Pages
From
Pseudomonas aeruginosa Pneumonia - Pipeline Review, H2 2018 - Product Thumbnail Image

Pseudomonas aeruginosa Pneumonia - Pipeline Review, H2 2018

  • Drug Pipelines
  • 33 Pages
From
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2018 - Product Thumbnail Image

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 165 Pages
From
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2018 - Product Thumbnail Image

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 152 Pages
From
Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2018 - Product Thumbnail Image

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 40 Pages
From
Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2018 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2018

  • Drug Pipelines
  • 241 Pages
From
Pseudomonas aeruginosa Pneumonia - Pipeline Review, H1 2018 - Product Thumbnail Image

Pseudomonas aeruginosa Pneumonia - Pipeline Review, H1 2018

  • Drug Pipelines
  • 36 Pages
From
Loading Indicator
adroll